<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: estrogen receptor</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>PI3K/mTOR pathway proteins tied to poor prognosis in breast cancer</title>
   	 <description>Four proteins involved in translation, the final step of general protein production, are associated with poor prognosis in hormone-receptor-positive breast cancer when they are dysregulated, researchers reported at the AACR Annual Meeting 2012.</description>
     <link>http://medicalxpress.com/news/2012-04-pi3kmtor-pathway-proteins-tied-poor.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 01 Apr 2012 12:32:10 EST</pubDate>
	 <guid isPermaLink="false">news252502306</guid>
	 
</item>
<item>
     <title>PET techniques provide more accurate diagnosis, prognosis in challenging breast cancer cases</title>
   	 <description>In two new studies featured in the February issue of the Journal of Nuclear Medicine, researchers are revealing how molecular imaging can be used to solve mysteries about difficult cases of breast cancer. One article focuses on an imaging agent that targets estrogen receptors in estrogen receptor&amp;#150;positive breast cancer patients with formerly inconclusive assessments, and the second highlights a different imaging agent's ability to help predict the prognosis for patients undergoing chemotherapy for a very aggressive type of breast cancer.</description>
     <link>http://medicalxpress.com/news/2012-02-pet-techniques-accurate-diagnosis-prognosis.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 06 Feb 2012 16:25:14 EST</pubDate>
	 <guid isPermaLink="false">news247767908</guid>
	 
</item>
<item>
     <title>Three new genetic links to breast cancer identified</title>
   	 <description>(Medical Xpress) -- An international team of researchers has identified three new genetic loci associated with an increased susceptibility to breast cancer. As described in their paper published in Nature Genetics, the three new loci will be added to the previous 22 that have been previously found and appear to be associated with mammary gland and bone growth and estrogen receptor signaling.</description>
     <link>http://medicalxpress.com/news/2012-01-genetic-links-breast-cancer.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 23 Jan 2012 14:20:04 EST</pubDate>
	 <guid isPermaLink="false">news246548659</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/breastcancer.jpg" width="90" height="90" />
</item>
<item>
     <title>Gender differences in liver cancer risk explained by small changes in genome</title>
   	 <description>Men are four times more likely to develop liver cancer compared to women, a difference attributed to the sex hormones androgen and estrogen. Although this gender difference has been known for a long time, the molecular mechanisms by which estrogens prevent -- and androgens promote -- liver cancer remain unclear.</description>
     <link>http://medicalxpress.com/news/2012-01-gender-differences-liver-cancer-small.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 19 Jan 2012 12:56:30 EST</pubDate>
	 <guid isPermaLink="false">news246200182</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/genderdiffer.jpg" width="90" height="83" />
</item>
<item>
     <title>New fermented soy ingredient containing S-equol significantly reduced hot flash frequency</title>
   	 <description>Daily doses of a soy germ-based nutritional supplement containing S-equol significantly improved menopausal symptoms, including significantly reducing hot flash frequency after 12 weeks according to a placebo-controlled study in postmenopausal Japanese women published in the peer-reviewed Journal of Women's Health.</description>
     <link>http://medicalxpress.com/news/2012-01-fermented-soy-ingredient-s-equol-significantly.html</link>
	 <category>Health</category>
	 <pubDate>Wed, 04 Jan 2012 15:16:55 EST</pubDate>
	 <guid isPermaLink="false">news244912607</guid>
	 
</item>
<item>
     <title>Zoledronic acid shows long-term benefit in survivorship for premenopausal ER-positive breast cancer</title>
   	 <description>Researchers have proven the continuing effectiveness of treating patients with estrogen receptor-positive premenopausal breast cancer with adjuvant zoledronic acid in addition to adjuvant endocrine treatment including ovarian function suppression.</description>
     <link>http://medicalxpress.com/news/2011-12-zoledronic-acid-long-term-benefit-survivorship.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 07 Dec 2011 10:50:02 EST</pubDate>
	 <guid isPermaLink="false">news242476739</guid>
	 
</item>
<item>
     <title>Breast cancer type linked to paternal cancer</title>
   	 <description>The risk of breast cancer is increased by genetic and lifestyle factors such as the inherited BRCA2 gene, age of having first child, or use of hormone replacement therapy (HRT). New research published in BioMed Central's open access journal BMC Cancer looked at the relationship between women with breast cancer and diagnosis of cancer in their parents. The results showed that the chances of women with lobular breast cancer having a father with cancer (especially prostate cancer) was almost twice as likely as women with other forms of breast cancer.</description>
     <link>http://medicalxpress.com/news/2011-11-breast-cancer-linked-paternal.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 28 Nov 2011 10:47:33 EST</pubDate>
	 <guid isPermaLink="false">news241699585</guid>
	 
</item>
<item>
     <title>PBX1 identified as a new pioneer factor underlying progression in breast cancer</title>
   	 <description>The presence of a new pioneer factor, known as PBX1, can guide the response to estrogen in breast cancer cells according to researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center in results published on November 17 in the open-access journal PLoS Genetics. This research reveals that PBX1 alone can determine the risk of the spread of cancer in patients with estrogen receptor alpha (ER&amp;#945;)-positive breast cancer, which accounts for about two-thirds of all breast cancers diagnosed in North America.</description>
     <link>http://medicalxpress.com/news/2011-11-pbx1-factor-underlying-breast-cancer.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 17 Nov 2011 17:43:51 EST</pubDate>
	 <guid isPermaLink="false">news240774225</guid>
	 
</item>
<item>
     <title>Cancer-causing protein strongly tied to hormone resistance in breast cancer</title>
   	 <description>In dozens of experiments in mice and in human cancer cells, a team of Johns Hopkins scientists has closely tied production of a cancer-causing protein called TWIST to the development of estrogen resistance in women with breast cancer.  Because estrogen fuels much breast cancer growth, such resistance &amp;#151; in which cancers go from estrogen positive to estrogen negative status &amp;#151; can sabotage anticancer drugs that work to block estrogen and prevent disease recurrence after surgery.  Estrogen resistance develops in over half of women taking estrogen-blocking medications, such as tamoxifen, and exists from the start in many other women.</description>
     <link>http://medicalxpress.com/news/2011-11-cancer-causing-protein-strongly-tied-hormone.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 16 Nov 2011 07:04:18 EST</pubDate>
	 <guid isPermaLink="false">news240649425</guid>
	 
</item>
<item>
     <title>New drug strategies for Alzheimer's, multiple sclerosis examined at UH</title>
   	 <description>Researchers at the University of Houston (UH) are recommending a new strategy for developing drugs to treat cancer, multiple sclerosis, Alzheimer's and cardiovascular diseases.</description>
     <link>http://medicalxpress.com/news/2011-10-drug-strategies-alzheimer-multiple-sclerosis.html</link>
	 <category>Alzheimer's disease &amp; dementia</category>
	 <pubDate>Thu, 20 Oct 2011 16:46:02 EST</pubDate>
	 <guid isPermaLink="false">news238347944</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/newdrugstrat.jpg" width="90" height="90" />
</item>
<item>
     <title>Study shows estrogen works in the brain to keep weight in check</title>
   	 <description>A recent UT Southwestern Medical Center study found that estrogen regulates energy expenditure, appetite and body weight, while insufficient estrogen receptors in specific parts of the brain may lead to obesity.</description>
     <link>http://medicalxpress.com/news/2011-10-estrogen-brain-weight.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 20 Oct 2011 02:50:01 EST</pubDate>
	 <guid isPermaLink="false">news238296281</guid>
	 
</item>
<item>
     <title>Protein that fuels lethal breast cancer growth emerges as potential new drug target</title>
   	 <description>A protein in the nucleus of breast cancer cells that plays a role in fueling the growth of aggressive tumors may be a good target for new drugs, reports a research team at the Duke Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2011-10-protein-fuels-lethal-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 17 Oct 2011 12:49:32 EST</pubDate>
	 <guid isPermaLink="false">news238074555</guid>
	 
</item>
<item>
     <title>Estrogen treatment may help reverse severe pulmonary hypertension</title>
   	 <description>UCLA researchers have found that the hormone estrogen may help reverse advanced pulmonary hypertension, a rare and serious condition that affects 2 to 3 million individuals in the U.S., mostly women, and can lead to heart failure.</description>
     <link>http://medicalxpress.com/news/2011-09-estrogen-treatment-reverse-severe-pulmonary.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 15 Sep 2011 13:07:13 EST</pubDate>
	 <guid isPermaLink="false">news235310805</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/estrogentrea.jpg" width="90" height="90" />
</item>
<item>
     <title>Study shows loss of key estrogen regulator may lead to metabolic syndrome and atherosclerosis</title>
   	 <description>UCLA researchers demonstrated that loss of a key protein that regulates estrogen and immune activity in the body could lead to aspects of metabolic syndrome, a combination of conditions that can cause Type 2 diabetes, atherosclerosis and cancer. Called estrogen receptor alpha, this protein is critical in regulating immune system activity such as helping cells suppress inflammation and gobble-up debris.</description>
     <link>http://medicalxpress.com/news/2011-09-loss-key-estrogen-metabolic-syndrome.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 06 Sep 2011 14:32:23 EST</pubDate>
	 <guid isPermaLink="false">news234538333</guid>
	 
</item>
<item>
     <title>UH researchers explore treatments for breast and colon cancers</title>
   	 <description>University of Houston (UH) researchers have their sights set on developing possible treatments for breast and colon cancer.</description>
     <link>http://medicalxpress.com/news/2011-08-uh-explore-treatments-breast-colon.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 22 Aug 2011 16:46:26 EST</pubDate>
	 <guid isPermaLink="false">news233250306</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/uhresearcher.jpg" width="90" height="90" />
</item>
<item>
     <title>PET scans confirm effectiveness of estrogen-blocking drugs in breast cancer patients</title>
   	 <description>For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer. The results of the research are published online in Clinical Cancer Research.</description>
     <link>http://medicalxpress.com/news/2011-08-pet-scans-effectiveness-estrogen-blocking-drugs.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 18 Aug 2011 10:46:17 EST</pubDate>
	 <guid isPermaLink="false">news232883156</guid>
	 
</item>
<item>
     <title>Higher estrogen production in the breast could confer greater cancer risk than thought</title>
   	 <description>Could some women who naturally produce excess aromatase in their breasts have an increased risk of developing breast cancer? Results of a new animal study suggests that may be the case, say researchers at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center.</description>
     <link>http://medicalxpress.com/news/2011-08-higher-estrogen-production-breast-confer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 12 Aug 2011 12:34:07 EST</pubDate>
	 <guid isPermaLink="false">news232371231</guid>
	 
</item>
<item>
     <title>Leukemia drug reverses tamoxifen-resistance in breast cancer cells</title>
   	 <description>Taking a leukemia chemotherapy drug may help breast cancer patients who don't respond to tamoxifen overcome resistance to the widely-used drug, new research from the Kimmel Cancer Center at Jefferson suggests.</description>
     <link>http://medicalxpress.com/news/2011-08-leukemia-drug-reverses-tamoxifen-resistance-breast.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 01 Aug 2011 12:30:06 EST</pubDate>
	 <guid isPermaLink="false">news231417656</guid>
	 
</item>
<item>
     <title>Key metabolic pathway implicated in intractable form of breast cancer</title>
   	 <description>Using a new in vivo screening system, Whitehead Institute researchers have identified a protein in the serine biosynthesis pathway that is essential in estrogen receptor (ER)-negative breast cancer&amp;#151;a notoriously difficult disease to treat associated with low five-year survival rates.</description>
     <link>http://medicalxpress.com/news/2011-07-key-metabolic-pathway-implicated-intractable.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 18 Jul 2011 16:52:22 EST</pubDate>
	 <guid isPermaLink="false">news230226730</guid>
	 
</item>
<item>
     <title>False negative tests in breast cancer may lead to wrong drug choice</title>
   	 <description>A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology.</description>
     <link>http://medicalxpress.com/news/2011-06-false-negative-breast-cancer-wrong.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 27 Jun 2011 16:00:33 EST</pubDate>
	 <guid isPermaLink="false">news228393756</guid>
	 
</item>
<item>
     <title>Obesity raises breast cancer survivors' risk of dying of the cancer</title>
   	 <description>Women with a healthy body weight before and after diagnosis of breast cancer are more likely to survive the disease long term, a new study finds.</description>
     <link>http://medicalxpress.com/news/2011-06-obesity-breast-cancer-survivors-dying.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 04 Jun 2011 14:50:01 EST</pubDate>
	 <guid isPermaLink="false">news226414491</guid>
	 
</item>
<item>
     <title>Emerging trends in radiation therapy for women over 70 with early stage breast cancer</title>
   	 <description>Patterns of radiation usage in breast conserving therapy for women 70 years and older with stage I breast cancer are changing: more women are opting for radioactive implants and those with estrogen positive tumors are opting out of radiation therapy, according to an abstract being presented at the American Society of Clinical Oncology annual meeting in Chicago by Thomas Jefferson University Hospital researchers on Saturday, June 4. The abstract (#6094) received an ASCO Merit Award.</description>
     <link>http://medicalxpress.com/news/2011-06-emerging-trends-therapy-women-early.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 02 Jun 2011 17:26:54 EST</pubDate>
	 <guid isPermaLink="false">news226254381</guid>
	 
</item>
<item>
     <title>Marker identifies breast cancer patients likely to respond to tamoxifen</title>
   	 <description>Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy.</description>
     <link>http://medicalxpress.com/news/2011-05-marker-breast-cancer-patients-tamoxifen.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 18 May 2011 10:12:32 EST</pubDate>
	 <guid isPermaLink="false">news224932338</guid>
	 
</item>
<item>
     <title>Sex hormone precursor inhibits brain inflammation</title>
   	 <description>Researchers at the University of California, San Diego School of Medicine have discovered a steroid hormone that inhibits inflammation in the brain. The findings, to be published in the May 13 issue of the journal Cell, have implications for understanding the exaggerated inflammatory responses that are characteristic features of numerous neurodegenerative diseases.</description>
     <link>http://medicalxpress.com/news/2011-05-sex-hormone-precursor-inhibits-brain.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 12 May 2011 12:27:54 EST</pubDate>
	 <guid isPermaLink="false">news224422037</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/sexhormonepr.jpg" width="90" height="90" />
</item>
<item>
     <title>Coffee reduces breast cancer risk: new study</title>
   	 <description>Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor (ER)-negative breast cancer.</description>
     <link>http://medicalxpress.com/news/2011-05-coffee-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 11 May 2011 03:32:02 EST</pubDate>
	 <guid isPermaLink="false">news224303484</guid>
	 
</item>
<item>
     <title>Estrogen-lowering drugs reduce mastectomy rates for breast cancer patients</title>
   	 <description>In the first large trial of its kind in the United States, researchers have shown that estrogen-lowering drugs can shrink tumors and reduce mastectomy rates for patients with stage 2 or 3 breast cancer.</description>
     <link>http://medicalxpress.com/news/2011-05-estrogen-lowering-drugs-mastectomy-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 09 May 2011 16:30:49 EST</pubDate>
	 <guid isPermaLink="false">news224177415</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/estrogenlowe.jpg" width="90" height="90" />
</item>
<item>
     <title>Researcher maps far-reaching effects of estrogen signaling in breast cancer cells</title>
   	 <description>A UT Southwestern Medical Center researcher has identified the most comprehensive measurement to date of estrogen's effect on breast cancer cells, showing for the first time how immediate and extensive the effect is.</description>
     <link>http://medicalxpress.com/news/2011-05-far-reaching-effects-estrogen-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 05 May 2011 13:02:51 EST</pubDate>
	 <guid isPermaLink="false">news223819346</guid>
	 
</item>


</channel>
</rss>
